My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 81

    1.

    Comparison of VerifyNow-P2Y12 test and Flow Cytometry for monitoring individual platelet response to clopidogrel. What is the cut-off value for identifying patients who are low responders to clopidogrel therapy?

    Godino C, Mendolicchio L, Figini F, Latib A, Sharp AS, Cosgrave J, Calori G, Cera M, Chieffo A, Castelli A, Maseri A, Ruggeri ZM, Colombo A.

    Thromb J. 2009 May 6;7:4.PMID: 19419580 [PubMed - in process]Free PMC ArticleFree textRelated citations

    2.

    Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.

    Malinin A, Pokov A, Spergling M, Defranco A, Schwartz K, Schwartz D, Mahmud E, Atar D, Serebruany V.

    Thromb Res. 2007;119(3):277-84. Epub 2006 Mar 24.PMID: 16563469 [PubMed - indexed for MEDLINE]Related citations

    3.

    Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.

    Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G.

    J Am Coll Cardiol. 2008 Sep 30;52(14):1128-33.PMID: 18804738 [PubMed - indexed for MEDLINE]Related citations

    4.

    Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients.

    Paniccia R, Antonucci E, Gori AM, Marcucci R, Giglioli C, Antoniucci D, Gensini GF, Abbate R, Prisco D.

    J Thromb Haemost. 2007 Sep;5(9):1839-47.PMID: 17723123 [PubMed - indexed for MEDLINE]Related citations

    5.

    Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.

    Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW.

    Thromb Haemost. 2009 Feb;101(2):333-9.PMID: 19190818 [PubMed - indexed for MEDLINE]Related citations

    6.

    Impact of P2Y12 inhibition by clopidogrel on cardiovascular mortality in unselected patients treated by percutaneous coronary angioplasty: a prospective registry.

    El Ghannudi S, Ohlmann P, Meyer N, Wiesel ML, Radulescu B, Chauvin M, Bareiss P, Gachet C, Morel O.

    JACC Cardiovasc Interv. 2010 Jun;3(6):648-56.PMID: 20630458 [PubMed - in process]Related citations

    7.

    Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel.

    Malinin A, Pokov A, Swaim L, Kotob M, Serebruany V.

    Methods Find Exp Clin Pharmacol. 2006 Jun;28(5):315-22.PMID: 16845449 [PubMed - indexed for MEDLINE]Related citations

    8.

    Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.

    Lordkipanidzé M, Pharand C, Nguyen TA, Schampaert E, Diodati JG.

    Ther Drug Monit. 2008 Jun;30(3):372-8.PMID: 18520610 [PubMed - indexed for MEDLINE]Related citations

    9.

    Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis.

    Pinto Slottow TL, Bonello L, Gavini R, Beauzile P, Sushinsky SJ, Scheinowitz M, Kaneshige K, Xue Z, Torguson R, Tantry U, Pichard AD, Satler LF, Suddath WO, Kent K, Gurbel P, Waksman R.

    Am J Cardiol. 2009 Aug 15;104(4):525-30. Epub 2009 Jun 24.PMID: 19660606 [PubMed - indexed for MEDLINE]Related citations

    10.

    Comparison of conventional aggregomerty with VASP for monitoring P2Y12-specifc platelet inhibition.

    Aradi D, Magyarlaki T, Tőkés-Füzesi M, Rideg O, Vorobcsuk A, Komócsi A.

    Platelets. 2010 Jul 19. [Epub ahead of print]PMID: 20642320 [PubMed - as supplied by publisher]Related citations

    11.

    Differential sensitivity and kinetics of response of different ex vivo tests monitoring functional variability of platelet response to clopidogrel.

    Bal Dit Sollier C, Berge N, Boval B, Dubar M, Drouet L.

    Thromb Haemost. 2010 Jul 20;104(3). [Epub ahead of print]PMID: 20664906 [PubMed - as supplied by publisher]Related citations

    12.

    Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.

    Hobson AR, Petley G, Morton G, Dawkins KD, Curzen NP.

    Thromb J. 2008 Feb 29;6:1.PMID: 18312665 [PubMed - in process]Free PMC ArticleFree textRelated citations

    13.

    Predictors of heightened platelet reactivity despite dual-antiplatelet therapy in patients undergoing percutaneous coronary intervention.

    Price MJ, Nayak KR, Barker CM, Kandzari DE, Teirstein PS.

    Am J Cardiol. 2009 May 15;103(10):1339-43. Epub 2009 Apr 1.PMID: 19427425 [PubMed - indexed for MEDLINE]Related citations

    14.

    The effects of aspirin and clopidogrel response on myonecrosis after percutaneous coronary intervention: a BRIEF-PCI (Brief Infusion of Intravenous Eptifibatide Following Successful Percutaneous Coronary Intervention) trial substudy.

    Saw J, Densem C, Walsh S, Jokhi P, Starovoytov A, Fox R, Wong G, Buller C, Ricci D, Mancini GB, Fung A.

    JACC Cardiovasc Interv. 2008 Dec;1(6):654-9.PMID: 19463380 [PubMed - indexed for MEDLINE]Related citations

    15.

    Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.

    Cuisset T, Frere C, Quilici J, Gaborit B, Castelli C, Poyet R, Bali L, Morange PE, Alessi MC, Bonnet JL.

    Am J Cardiol. 2009 Oct 15;104(8):1078-82.PMID: 19801028 [PubMed - indexed for MEDLINE]Related citations

    16.

    Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin.

    Varenhorst C, James S, Erlinge D, Braun OO, Brandt JT, Winters KJ, Jakubowski JA, Olofsson S, Wallentin L, Siegbahn A.

    Am Heart J. 2009 Mar;157(3):562.e1-9. Epub 2009 Feb 6.PMID: 19249429 [PubMed - indexed for MEDLINE]Related citations

    17.

    A Comparison of VerifyNow P2Y12 Point-of-Care Device and Light Transmission Aggregometry to Monitor Platelet Function with Prasugrel and Clopidogrel: An Integrated Analysis.

    Jakubowski JA, Li YG, Small DS, Payne CD, Tomlin ME, Luo J, Winters KJ.

    J Cardiovasc Pharmacol. 2010 Mar 24. [Epub ahead of print]PMID: 20351563 [PubMed - as supplied by publisher]Related citations

    18.

    A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis.

    Jakubowski JA, Li YG, Small DS, Payne CD, Tomlin ME, Luo J, Winters KJ.

    J Cardiovasc Pharmacol. 2010 Jul;56(1):29-37.PMID: 20386460 [PubMed - in process]Related citations

    19.

    Correlation of high post-treatment platelet reactivity assessed by light transmittance aggregometry and the VerifyNow P2Y(12) assay.

    Kim IS, Jeong YH, Kang MK, Koh JS, Park Y, Hwang SJ, Kwak CH, Hwang JY, Kim S.

    J Thromb Thrombolysis. 2010 May 7. [Epub ahead of print]PMID: 20449634 [PubMed - as supplied by publisher]Related citations

    20.

    Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting.

    Campo G, Valgimigli M, Carrescia C, Carletti R, Ferrari R.

    Clin Appl Thromb Hemost. 2009 Jun 10. [Epub ahead of print]PMID: 19520678 [PubMed - as supplied by publisher]Related citations

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...
    You are here: NCBI > Literature > PubMed
    Write to the Help Desk